Mehmet Toptas
Research Subjects
Mehmet Toptas has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Ibrahim Akkoc
Department of Anesthesiology and Reanimation, Haseki Education and Research Hospital, Istanbul, Turkey
7 shared publications - Kemal Karapınar
Univ Hlth Sci Turkey, Yedikule Chest Dis & Thorac Surg Training & Res H, Clin Chest Surg, Istanbul, Turkey
4 shared publications - Sibel Yurt
Basaksehir Cam and Sakura City Hospital, Department of Pulmonology, Istanbul, Turkey
4 shared publications - Eren Demir
Haseki Training and Research Hospital, Turkey
3 shared publications - Murat Haliloğlu
Univ Hlth Sci Turkey, Yedikule Chest Dis & Thorac Surg Training & Res H, Unit Intens Care, Istanbul, Turkey
3 shared publications - Oznur Sen
Department of Anesthesiology and Reanimation, Ministry of Health Haseki Training and Research Hospital, Istanbul, Turkey
3 shared publications
Latest Publications
- Open Access
Serum osmolarity as a predictor of mortality in ICU COVID-19 patients: a retrospective analysis
Background: Serum osmolarity, reflecting fluid and electrolyte balance, may serve as a prognostic marker in critically ill patients, but its role in COVID-19 is not well established. This study evaluated the association between admission serum osmolarity and in-hospital mortality in critically ill COVID-19 patients. Methods: We conducted a retrospective study including 267 critically ill COVID-19 patients admitted from the ED to the ICU of a tertiary-care hospital between March 2020 and April 2022. Data on demographics, thoracic computed tomography (CT) findings, vasopressor use, ventilation support, laboratory values, and in-hospital mortality were obtained. Serum osmolarity was calculated using the formula. The primary outcome was in-hospital mortality; secondary outcomes included vasopressor use, endotracheal intubation (ETI), and laboratory parameters. Statistical analyses included Mann–Whitney U and chi-square tests, logistic regression, and receiver operating characteristic (ROC) curve analysis. Results: Of 267 patients, 203 were non-survivors and 64 survivors (mortality 76%); mean age was 53.8 ± 12.3 years, 59.6% male. Survivors had higher median serum osmolarity (288.37 vs. 285.75 mOsm/L, p = 0.034) and sodium (Na) (135 vs. 133 mEq/L, p = 0.004). Sodium demonstrated slightly superior discrimination (AUC = 0.620) compared to osmolarity (area under the curve (AUC) = 0.588). In multivariate logistic regression, serum sodium (OR = 0.89, 95% CI 0.82–0.97), inotropic agent use (OR = 3.73, 95% CI [1.65–8.42]), and endotracheal intubation (OR = 5.20, 95% CI [2.11–12.84]) were independent predictors of mortality. The model’s c-statistic was 0.713 (95% CI [0.654–0.771]) with 70.4% sensitivity and 65.8% specificity. Conclusions: Lower admission serum osmolarity and hyponatremia were independently associated with increased in-hospital mortality in critically ill COVID-19 patients. Although Na slightly outperformed calculated osmolarity, the latter remains a practical, integrative prognostic tool for early risk stratification. Prospective studies should evaluate whether timely correction of hypo-osmolar or hyponatremic states improves outcomes.
Open AccessSerum osmolarity as a predictor of mortality in ICU COVID-19 patients: a retrospective analysis
Background: Serum osmolarity, reflecting fluid and electrolyte balance, may serve as a prognostic marker in critically ill patients, but its role in COVID-19 is not well established. This study evaluated the association between admission serum osmolarity and in-hospital mortality in critically ill COVID-19 patients. Methods: We conducted a retrospective study including 267 critically ill COVID-19 patients admitted from the ED to the ICU of a tertiary-care hospital between March 2020 and April 2022. Data on demographics, thoracic computed tomography (CT) findings, vasopressor use, ventilation support, laboratory values, and in-hospital mortality were obtained. Serum osmolarity was calculated using the formula. The primary outcome was in-hospital mortality; secondary outcomes included vasopressor use, endotracheal intubation (ETI), and laboratory parameters. Statistical analyses included Mann–Whitney U and chi-square tests, logistic regression, and receiver operating characteristic (ROC) curve analysis. Results: Of 267 patients, 203 were non-survivors and 64 survivors (mortality 76%); mean age was 53.8 ± 12.3 years, 59.6% male. Survivors had higher median serum osmolarity (288.37 vs. 285.75 mOsm/L, p = 0.034) and sodium (Na) (135 vs. 133 mEq/L, p = 0.004). Sodium demonstrated slightly superior discrimination (AUC = 0.620) compared to osmolarity (area under the curve (AUC) = 0.588). In multivariate logistic regression, serum sodium (OR = 0.89, 95% CI 0.82–0.97), inotropic agent use (OR = 3.73, 95% CI [1.65–8.42]), and endotracheal intubation (OR = 5.20, 95% CI [2.11–12.84]) were independent predictors of mortality. The model’s c-statistic was 0.713 (95% CI [0.654–0.771]) with 70.4% sensitivity and 65.8% specificity. Conclusions: Lower admission serum osmolarity and hyponatremia were independently associated with increased in-hospital mortality in critically ill COVID-19 patients. Although Na slightly outperformed calculated osmolarity, the latter remains a practical, integrative prognostic tool for early risk stratification. Prospective studies should evaluate whether timely correction of hypo-osmolar or hyponatremic states improves outcomes.
- 24 May 2024
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 25 (2) , 165-169
Ketamine as a Supplementary Analgosedative in COVID-19 Patients on Mechanical Ventilation: A Single-Center Observational Study
- 24 May 2024
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 25 (2) , 165-169
Ketamine as a Supplementary Analgosedative in COVID-19 Patients on Mechanical Ventilation: A Single-Center Observational Study
- Open Access
- 9 February 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (6) , e37186
Selection of the appropriate treatment for the combination of interstitial lung disease and lung cancer: A retrospective observational study
Interstitial lung disease (ILD) independently heightens the risk of lung cancer (LC), often necessitating chemoradiotherapy (CRT) due to advanced disease stages. However, CRT may compromise survival through complications such as ILD exacerbation or radiation pneumonitis. The aim of this study was to determine the optimal surgical or nonsurgical treatment approaches for patients with concurrent ILD and LC. Over a 10-year period, a retrospective evaluation was conducted on 647 patients with confirmed diagnoses of LC and ILD from a total of 4541 patients examined in the polyclinic. This assessment included a comprehensive review of demographic, treatment, and survival records. Study groups included those treated for both ILD and LC with surgical treatment (ST), chemotherapy (CT), radiotherapy (RT), or CRT. A control group comprised ILD-only cases. In the whole sample of 647 patients with complete data, the length of stay in hospital and respiratory intensive care unit was significantly shorter in the ST group and longer in the CT group. Significant differences in discharge status (P < .001) were observed, with higher recovery rates in the ST and RT groups. The CT group showed an increased rate of transfer to other centers, in-hospital mortality was determined to be higher in the CRT group, and the control group exhibited no change in discharge. No statistically significant difference was determined between the groups with respect to the 24- and 48-month survival rates (P = .100). Although no disparity was found in 2- and 4-year survival rates, there were seen to be advantages in survival and quality of life with the addition of radiotherapy to regions aligning with surgical margins for LC patients with ILD, evaluated as radiological N0, undergoing wedge resection. This underscores the need for personalized treatment strategies to balance effective cancer control and to minimize ILD-related complications.
- 9 February 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (6) , e37186
Open AccessSelection of the appropriate treatment for the combination of interstitial lung disease and lung cancer: A retrospective observational study
Interstitial lung disease (ILD) independently heightens the risk of lung cancer (LC), often necessitating chemoradiotherapy (CRT) due to advanced disease stages. However, CRT may compromise survival through complications such as ILD exacerbation or radiation pneumonitis. The aim of this study was to determine the optimal surgical or nonsurgical treatment approaches for patients with concurrent ILD and LC. Over a 10-year period, a retrospective evaluation was conducted on 647 patients with confirmed diagnoses of LC and ILD from a total of 4541 patients examined in the polyclinic. This assessment included a comprehensive review of demographic, treatment, and survival records. Study groups included those treated for both ILD and LC with surgical treatment (ST), chemotherapy (CT), radiotherapy (RT), or CRT. A control group comprised ILD-only cases. In the whole sample of 647 patients with complete data, the length of stay in hospital and respiratory intensive care unit was significantly shorter in the ST group and longer in the CT group. Significant differences in discharge status (P < .001) were observed, with higher recovery rates in the ST and RT groups. The CT group showed an increased rate of transfer to other centers, in-hospital mortality was determined to be higher in the CRT group, and the control group exhibited no change in discharge. No statistically significant difference was determined between the groups with respect to the 24- and 48-month survival rates (P = .100). Although no disparity was found in 2- and 4-year survival rates, there were seen to be advantages in survival and quality of life with the addition of radiotherapy to regions aligning with surgical margins for LC patients with ILD, evaluated as radiological N0, undergoing wedge resection. This underscores the need for personalized treatment strategies to balance effective cancer control and to minimize ILD-related complications.
- 1 August 2023
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 24 (3) , 312-315
Comparison of Spinal Anesthesia vs. Local Infiltration Anesthesia in Postoperative Pain in Patients Undergoing Sinusectomy Surgery
- 1 August 2023
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 24 (3) , 312-315
Comparison of Spinal Anesthesia vs. Local Infiltration Anesthesia in Postoperative Pain in Patients Undergoing Sinusectomy Surgery
- 1 February 2023
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 24 (1) , 32-35
Evaluation of Subclavian Central Venous Port Catheters Placed by Anesthesiologists: Single-Center Experience
- 1 February 2023
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 24 (1) , 32-35
Evaluation of Subclavian Central Venous Port Catheters Placed by Anesthesiologists: Single-Center Experience
- 1 August 2022
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 23 (3) , 205-209
Predicting Length of Stay and Mortality in Acute Exacerbation of Chronic Obstructive Pulmonary Disease at the Intensive Care Unit
- 1 August 2022
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 23 (3) , 205-209
Predicting Length of Stay and Mortality in Acute Exacerbation of Chronic Obstructive Pulmonary Disease at the Intensive Care Unit
- 1 February 2021
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 22 (1) , 13-18
Is Sarcopenia Related to Mortality in Patients with Chronic Obstructive Pulmonary Disease in the Intensive Care Unit?
- 1 February 2021
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 22 (1) , 13-18
Is Sarcopenia Related to Mortality in Patients with Chronic Obstructive Pulmonary Disease in the Intensive Care Unit?
- 30 December 2020
- Published by Cagdas Tip Dergisi: Journal of Contemporary Medicine in Journal of Contemporary Medicine
- Vol. 10 (4) , 481-486
Can neutrophil-lymphocyte ratio and platelet-lymphocyte ratio be related with skeletal mass area in COPD patients with acute exacerbation?
Introduction:This study was designed to assess whether there is a relation between inflammatory biomarkers such as NLR, PLR and psoas muscle area (PMA) as a marker of sarcopenia in COPD pateints who admitted to the emergency department of our clinic. Method: Retrospectivly one hundred forty three COPD patients who had CT scan for any reason during hospital admission were included. Patient characteristics and clinical and laboratory data were evaluated retrospectively. Results:In our study, we performed the correlations between NLR, PLR and CRP, FEV1, FVC, FEV1/FVC, right PMA, left PMA, total PMA. NLR and PLR were positively correlated with CRP (r=0.60, p
- 30 December 2020
- Published by Cagdas Tip Dergisi: Journal of Contemporary Medicine in Journal of Contemporary Medicine
- Vol. 10 (4) , 481-486
Can neutrophil-lymphocyte ratio and platelet-lymphocyte ratio be related with skeletal mass area in COPD patients with acute exacerbation?
Introduction:This study was designed to assess whether there is a relation between inflammatory biomarkers such as NLR, PLR and psoas muscle area (PMA) as a marker of sarcopenia in COPD pateints who admitted to the emergency department of our clinic. Method: Retrospectivly one hundred forty three COPD patients who had CT scan for any reason during hospital admission were included. Patient characteristics and clinical and laboratory data were evaluated retrospectively. Results:In our study, we performed the correlations between NLR, PLR and CRP, FEV1, FVC, FEV1/FVC, right PMA, left PMA, total PMA. NLR and PLR were positively correlated with CRP (r=0.60, p
- 1 March 2020
- Published by Galenos Yayinevi in Medical Bulletin of Haseki
- Vol. 58 (2) , 200-207
Efficacy of Presepsin as a Biomarker of Sepsis and Its Prognostic Value for Prediction of Mortality
- 1 March 2020
- Published by Galenos Yayinevi in Medical Bulletin of Haseki
- Vol. 58 (2) , 200-207
Efficacy of Presepsin as a Biomarker of Sepsis and Its Prognostic Value for Prediction of Mortality
- Open Access
- 1 January 2020
- Published by Wiley in BioMed Research International
- Vol. 2020 (1) , 1586707
Psoas Muscle Area Measured with Computed Tomography at Admission to Intensive Care Unit: Prediction of In‐Hospital Mortality in Patients with Pulmonary Embolism
Aim. Sarcopenia, a core component of physical frailty, is an independent risk factor for suboptimal health outcomes in hospitalized patients, especially in the intensive care patients. Psoas muscle areas can be assessed to identify sarcopenia. The aim of this study was to determine the prognostic value of psoas muscle area measured with CT for the prediction of in‐hospital mortality in patients with pulmonary embolism at admission to the intensive care unit. Methods. Patients with an admission abdominal computed tomography scan and requiring intensive care unit (ICU) stay were reviewed. Selected clinical data of patients admitted to intensive care unit for the management of pulmonary embolism were collected. Using CT scan images at the level of L3 vertebra, the psoas muscle area value was obtained by dividing the sum of the right and left psoas muscle areas into the body surface area. Results. In‐hospital mortality rate was 22.5% in 89 patients. The pulmonary embolism patients with in‐hospital mortality had higher PESI and lower value of psoas muscle area, in addition to the lower systolic blood pressure and arterial oxygen saturation at admission. The increase in the value of psoas muscle area is associated with a decrease in the rate of in‐hospital mortality. In patients with in‐hospital mortality related to pulmonary embolism, the higher PESI and the lower value of psoas muscle area were considered in accordance with the outcome of patients. Conclusions. For the prediction of in‐hospital mortality risk in patients with pulmonary embolism managed in intensive care unit, the psoas muscle area value has a merit to be used among the routine diagnostic procedures after further studies conducted with different severity of pulmonary embolism.
- 1 January 2020
- Published by Wiley in BioMed Research International
- Vol. 2020 (1) , 1586707
Open AccessPsoas Muscle Area Measured with Computed Tomography at Admission to Intensive Care Unit: Prediction of In‐Hospital Mortality in Patients with Pulmonary Embolism
Aim. Sarcopenia, a core component of physical frailty, is an independent risk factor for suboptimal health outcomes in hospitalized patients, especially in the intensive care patients. Psoas muscle areas can be assessed to identify sarcopenia. The aim of this study was to determine the prognostic value of psoas muscle area measured with CT for the prediction of in‐hospital mortality in patients with pulmonary embolism at admission to the intensive care unit. Methods. Patients with an admission abdominal computed tomography scan and requiring intensive care unit (ICU) stay were reviewed. Selected clinical data of patients admitted to intensive care unit for the management of pulmonary embolism were collected. Using CT scan images at the level of L3 vertebra, the psoas muscle area value was obtained by dividing the sum of the right and left psoas muscle areas into the body surface area. Results. In‐hospital mortality rate was 22.5% in 89 patients. The pulmonary embolism patients with in‐hospital mortality had higher PESI and lower value of psoas muscle area, in addition to the lower systolic blood pressure and arterial oxygen saturation at admission. The increase in the value of psoas muscle area is associated with a decrease in the rate of in‐hospital mortality. In patients with in‐hospital mortality related to pulmonary embolism, the higher PESI and the lower value of psoas muscle area were considered in accordance with the outcome of patients. Conclusions. For the prediction of in‐hospital mortality risk in patients with pulmonary embolism managed in intensive care unit, the psoas muscle area value has a merit to be used among the routine diagnostic procedures after further studies conducted with different severity of pulmonary embolism.